IVUS    Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound Am Heart J, 2010. 159(2): p. 271-7. T. Kubo, et al., Impact of different re-stenting strategies on expansion of a drug-eluting stent implanted to treat bare-metal stent restenosis Am J Cardiol, 2009. 104(4): p. 531-7. L. Kalinczuk, et al., Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry) Am J Cardiol, 2009. 103(9): p. 1210-4. J. Qian, et al., Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis Circ Cardiovasc Interv, 2009. 2(3): p. 167-77. S. J. Park, et al., Impact of myocardial bridge on clinical outcome after coronary stent placement Am J Cardiol, 2009. 103(10): p. 1344-8. K. Tsujita, et al., Impact of NAD(P)H oxidase-derived reactive oxygen species on coronary arterial remodeling: a comparative intravascular ultrasound and histochemical analysis of atherosclerotic lesions Circ Cardiovasc Interv, 2009. 2(3): p. 196-204. M. Terashima, et al., Impact of plaque characteristics analyzed by intravascular ultrasound on long-term clinical outcomes Am J Cardiol, 2009. 103(9): p. 1221-6. S. H. Kim, et al., Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis Eur Heart J, 2009. Y. J. Hong, et al., Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis JACC Cardiovasc Imaging, 2009. 2(4): p. 458-68. Y. J. Hong, et al., Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials JACC Cardiovasc Interv, 2009. 2(12): p. 1269-75. H. Doi, et al., In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography JACC Cardiovasc Imaging, 2009. 2(4): p. 473-82. N. Gonzalo, et al., In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study Circulation, 2009. 119(21): p. 2829-36. Y. Mitani, et al., In vivo validation of CAAS QCA-3D coronary reconstruction using fusion of angiography and intravascular ultrasound (ANGUS) Catheter Cardiovasc Interv, 2009. 73(5): p. 620-6. J. C. Schuurbiers, et al., Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression J Am Coll Cardiol, 2009. 53(15): p. 1279-86. E. Raichlin, et al., An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents Am J Cardiol, 2009. 103(4): p. 501-6. J. Liu, et al., Intravascular ultrasound and 3D angle measurements of coronary bifurcations Catheter Cardiovasc Interv, 2009. 73(7): p. 910-6. E. C. van der Waal, et al., Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation JACC Cardiovasc Interv, 2009. 2(10): p. 997-1004. X. Liu, et al., Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions JACC Cardiovasc Interv, 2009. 2(9): p. 846-54. K. Tsujita, et al., Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS Catheter Cardiovasc Interv, 2009. J. Jakabcin, et al., Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis J Am Coll Cardiol, 2009. 53(13): p. 1110-5. A. K. Chhatriwalla, et al., MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses Eur Heart J, 2009. 30(12): p. 1477-85. Y. Onuma, et al., Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy JACC Cardiovasc Interv, 2009. 2(10): p. 989-94. F. Sera, et al., Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions Am J Cardiol, 2010. 105(2): p. 179-85. Y. J. Hong, et al., Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients JACC Cardiovasc Imaging, 2009. 2(3): p. 339-49. Y. J. Hong, et al., Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosis Heart, 2009. 95(24): p. 1990-6. J. E. van Velzen, et al., Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography J Am Coll Cardiol, 2009. 53(25): p. 2363-71. M. A. Leesar, et al., A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study) JACC Cardiovasc Interv, 2009. 2(6): p. 524-31. T. Takagi, et al., A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction J Am Coll Cardiol, 2009. 53(18): p. 1653-9. J. W. Kim, et al., Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2 Circ Cardiovasc Interv, 2009. 2(3): p. 188-95. B. Chevalier, et al., A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial) Circ Cardiovasc Interv, 2009. 2(2): p. 113-23. R. J. Russo, et al., Relation between individual plaque components and overall plaque burden in the prospective, multicenter virtual histology intravascular ultrasound registry Am J Cardiol, 2009. 104(4): p. 501-6. J. Qian, et al., Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques Heart, 2009. 95(18): p. 1525-30. S. Lavi, et al., Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent Am J Cardiol, 2009. 104(9): p. 1216-21. H. Doi, et al., Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus Am J Cardiol, 2009. 103(8): p. 1083-8. L. O. Jensen, et al., Serial intravascular ultrasound analysis of the main and side branches in bifurcation lesions treated with the T-stenting technique J Am Coll Cardiol, 2009. 54(2): p. 110-7. J. Y. Hahn, et al., Synergistic effect of cardiovascular risk factors on necrotic core in coronary arteries: a report from the global intravascular radiofrequency data analysis registry JACC Cardiovasc Imaging, 2009. 2(5): p. 629-36. H. M. Garcia-Garcia, et al., TAXUS Liberte attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program JACC Cardiovasc Interv, 2009. 2(3): p. 240-52. E. Mahmud, et al., Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial Circ Cardiovasc Interv, 2009. 2(4): p. 339-47. B. E. Claessen, et al., Virtual histology intravascular ultrasound analysis of non-culprit attenuated plaques detected by grayscale intravascular ultrasound in patients with acute coronary syndromes Am J Cardiol, 2010. 105(1): p. 48-53. X. Wu, et al., Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy Circulation, 2009. 120(19): p. 1875-82. A. Maehara, et al., A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis JACC Cardiovasc Interv, 2009. 2(5): p. 428-34. X. Liu, et al., 9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study J Am Coll Cardiol, 2009. 53(12): p. 1031-9. S. Verheye, et al., Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome Am J Cardiol, 2009. 104(6): p. 750-7. J. Rodes-Cabau, et al., Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment Am J Cardiol, 2009. 104(4): p. 464-9. S. Tani, et al., Association of plaque composition and vessel remodeling in atherosclerotic renal artery stenosis: a comparison with coronary artery disease JACC Cardiovasc Imaging, 2009. 2(3): p. 327-38. T. Kataoka, et al., A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet, 2009. 373(9667): p. 897-910. P. W. Serruys, et al., Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture Am J Cardiol, 2009. 103(6): p. 818-23. H. Doi, et al., Clinical significance of echo signal attenuation on intravascular ultrasound in patients with coronary artery disease Circ Cardiovasc Interv, 2009. 2(5): p. 444-54. S. Kimura, et al., Comparison of inflammatory markers and angiographic outcomes after implantation of sirolimus and paclitaxel-eluting stents Heart, 2009. 95(12): p. 970-5. W. C. Kang, et al., Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries Am J Cardiol, 2009. 103(4): p. 496-500. L. Bonello, et al., Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings J Am Coll Cardiol, 2009. 53(22): p. 2053-60. F. Alfonso, et al., Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study Catheter Cardiovasc Interv, 2009. 74(2): p. 348-56. R. T. Gerber, et al., Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology Circ Cardiovasc Interv, 2009. 2(6): p. 543-8. J. B. Lindsey, et al., Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis J Am Coll Cardiol, 2009. 53(15): p. 1257-64. Y. J. Hong, et al., Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry Eur Heart J, 2010. 31(2): p. 196-202. S. Philipp, et al., Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries JACC Cardiovasc Interv, 2009. 2(4): p. 312-20. R. Waksman, et al., Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome Am J Cardiol, 2009. 103(6): p. 791-5. H. Okura, et al., Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound JACC Cardiovasc Interv, 2009. 2(7): p. 689-96. K. Nasu, et al., Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study) J Am Coll Cardiol, 2009. 54(4): p. 293-302. T. Hiro, et al., Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis JACC Cardiovasc Interv, 2009. 2(7): p. 679-88. M. K. Hong, et al., Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation Heart, 2009. 95(13): p. 1079-84. H. Kaneda, et al., Evaluation of intermediate coronary stenosis with intravascular ultrasound and fractional flow reserve: Its use and abuse Catheter Cardiovasc Interv, 2009. 73(4): p. 441-8. V. Magni, A. Chieffo and A. Colombo, First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trial JACC Cardiovasc Interv, 2009. 2(3): p. 197-204. C. Tamburino, et al., High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trials Am J Cardiol, 2009. 104(10 Suppl): p. 16E-21E. S. J. Nicholls,